As per recent market analysis, the global downstream processing industry demand is set to witness an impressive growth trajectory, estimated to reach a substantial value of US$ 72.3 billion by the end of 2032. This growth is projected at a Compound Annual Growth Rate (CAGR) of 11.3% from 2022 to 2032, marking a sign.
The extraction, purification, and refinement of important bioproducts are crucial tasks for the downstream processing market in the dynamic fields of industrial biotechnology and biopharmaceuticals. This crucial but frequently skipped phase makes ensuring that biopharmaceuticals, enzymes, biofuels, and other biotech.